Clariant AG

BATS-CHIXE:CLNZ Stock Report

Market Cap: CHF 3.6b

Clariant Valuation

Is CLNZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CLNZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CLNZ (CHF10.87) is trading below our estimate of fair value (CHF23.57)

Significantly Below Fair Value: CLNZ is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLNZ?

Key metric: As CLNZ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CLNZ. This is calculated by dividing CLNZ's market cap by their current revenue.
What is CLNZ's PS Ratio?
PS Ratio0.7x
SalesCHF 4.92b
Market CapCHF 3.59b

Price to Sales Ratio vs Peers

How does CLNZ's PS Ratio compare to its peers?

The above table shows the PS ratio for CLNZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.6x
JMAT Johnson Matthey
0.3x-58.31%UK£3.5b
CRDA Croda International
2.3x4.77%UK£3.8b
ELM Elementis
1.7x-3.21%UK£936.1m
VCT Victrex
2x3.84%UK£581.0m
CLNZ Clariant
0.7x1.89%CHF 3.6b

Price-To-Sales vs Peers: CLNZ is good value based on its Price-To-Sales Ratio (0.7x) compared to the peer average (2.3x).

Price to Sales Ratio vs Industry

How does CLNZ's PS Ratio compare vs other companies in the GB Chemicals Industry?

4 CompaniesPrice / SalesEstimated GrowthMarket Cap
SYNT Synthomer
0.05x3.02%US$133.80m
HEIQ HeiQ
0.2xn/aUS$9.61m
BYOT Byotrol
0.1xn/aUS$569.29k
BIOM Biome Technologies
0.07x33.12%US$499.55k
No more companies available in this PS range
No. of Companies4PS012345+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CLNZ is good value based on its Price-To-Sales Ratio (0.7x) compared to the UK Chemicals industry average (1.3x).

Price to Sales Ratio vs Fair Ratio

What is CLNZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLNZ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.7x
Fair PS Ratio0.9x

Price-To-Sales vs Fair Ratio: CLNZ is good value based on its Price-To-Sales Ratio (0.7x) compared to the estimated Fair Price-To-Sales Ratio (0.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CLNZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Oct ’26n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Sep ’26n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Aug ’26n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Jul ’26n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Jun ’26n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
May ’26n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Apr ’26n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Mar ’26n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Feb ’26n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Jan ’26n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Dec ’25n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Nov ’25n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Oct ’25n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Sep ’25n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Aug ’25n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Jul ’25n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
Jun ’25n/a
CHF 15.04
0%
12.34%CHF 20.00CHF 11.50n/a14
May ’25CHF 13.86
CHF 15.04
+8.53%
12.34%CHF 20.00CHF 11.50n/a14
Apr ’25CHF 12.17
CHF 15.04
+23.61%
12.34%CHF 20.00CHF 11.50n/a14
Mar ’25CHF 10.95
CHF 15.04
+37.38%
12.34%CHF 20.00CHF 11.50n/a14
Feb ’25CHF 11.09
CHF 15.04
+35.64%
12.34%CHF 20.00CHF 11.50n/a14
Jan ’25CHF 12.41
CHF 15.47
+24.67%
11.29%CHF 20.00CHF 13.00n/a14
Dec ’24CHF 13.05
CHF 16.11
+23.42%
13.92%CHF 22.00CHF 13.90n/a15
Nov ’24CHF 12.93
CHF 16.11
+24.57%
13.92%CHF 22.00CHF 13.90n/a15
Oct ’24n/a
CHF 16.27
0%
13.16%CHF 22.00CHF 14.00n/a15

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/01/22 08:09
End of Day Share Price 2024/01/19 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Clariant AG is covered by 38 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Konstantin WiechertBaader Helvea Equity Research
Robert BateBarclays